Key result
Quinidine, procainamide, and hypokalemia prolonged ventricular repolarization and delayed the rate adaptation of the QT interval and APD, whereas lidocaine had no effect.
Why the study?
Do arrhythmogenic drugs (quinidine, procainamide) and hypokalemia delay the rate adaptation of ventricular repolarization compared to baseline or lidocaine in isolated guinea-pig hearts?
Do arrhythmogenic drugs (quinidine, procainamide) and hypokalemia delay the rate adaptation of ventricular repolarization compared to baseline or lidocaine in isolated guinea-pig hearts?
Arrhythmogenic interventions like quinidine, procainamide, and hypokalemia delay the rate adaptation of ventricular repolarization, which may contribute to their proarrhythmic effects, unlike the safe agent lidocaine.
May warrant caution in repolarization assessment with proarrhythmic drugs; leaves open clinical validation of APD adaptation metrics.
Objectives. In normal conditions, sudden heart rate acceleration provokes a rapid reduction in ventricular action potential duration (APD). The protracted APD rate adaptation favors early afterdepolarizations and precipitates arrhythmia. Nevertheless, it is uncertain as to whether the rate-dependent changes of ventricular repolarization can be adversely modified by arrhythmogenic drugs (quinidine and procainamide) and hypokalemia, in comparison to the agents with safe therapeutic profile, such as lidocaine. Design. The rate adaptation of QT interval and monophasic APD obtained from the left ventricular (LV) and the right ventricular (RV) epicardium was examined during rapid cardiac pacing applied in isolated, perfused guinea-pig heart preparations. Results. At baseline, an abrupt increase in cardiac activation rate was associated with a substantial reduction of the QT interval and ventricular APD in the first two cardiac cycles, which was followed by a gradual shortening of repolarization over subsequent pacing intervals. The time constants of the fast (τfast) and slow (τslow) components of the APD dynamics determined from a double exponential fit were longer in RV compared to LV chamber. Quinidine, procainamide, and hypokalemia prolonged ventricular repolarization and delayed the rate adaptation of the QT interval and APD in LV and RV, as evidenced by increased τfast and τslow values. In contrast, lidocaine had no effect on the dynamic changes of ventricular repolarization upon heart rate acceleration. Conclusions. The rate adaptation of ventricular repolarization is delayed by arrhythmogenic interventions, such as quinidine, procainamide, and hypokalemia, but not changed by lidocaine, a clinically safe antiarrhythmic agent.
No takes yet. Share an insight, caveat, or question.
Oleg E. Osadchii (2018) studied this question. Quinidine, procainamide, and hypokalemia vs. Lidocaine and baseline was evaluated on Rate adaptation of QT interval and monophasic APD (time constants τfast and τslow). Quinidine, procainamide, and hypokalemia prolonged ventricular repolarization and delayed the rate adaptation of the QT interval and APD, whereas lidocaine had no effect.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: